title: Targeting Th17 cells in immune diseases.
abstract: Last decade has seen quick developments in the understanding of a new type of T lymphocytes, Th17 cells. This information is benefiting the understanding and treatment of a variety of inflammatory diseases, as suggested by a recent paper in Immunity.
authors.affiliation: Tsinghua University School of Medicine, Beijing 100084, China.
authors.forename: Chen
authors.initials: C
authors.lastname: Dong
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000276:immunology*; D017124:Conserved Sequence; D005786:Gene Expression Regulation / Q000276:immunology*; D053263:Gene Regulatory Networks; D006801:Humans; D020381:Interleukin-17 / Q000096:biosynthesis* / Q000235:genetics*; D008231:Lymphopenia / Q000276:immunology* / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D058727:RNA, Small Untranslated; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000378:metabolism*; D058504:Th17 Cells / Q000166:cytology* / Q000378:metabolism*
chemical_list: D020381:Interleukin-17; D058727:RNA, Small Untranslated